GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
Rating: OMED
Buy $45

Oncomed Pharmaceuticals Inc. (NASDAQ: OMED) rated to Buy with price target $45 by Mizuho

Tuesday,  Feb 11, 2014  8:25 AM ET by Lynn Gilbert

Mizuho rated Oncomed Pharmaceuticals
Inc. (NASDAQ: OMED) to Buy with price target $45.



Mizuho



RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy